Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The number of admissions to hospital with heart attacks fell by 35% by the end of March.

Image of a stethoscope with a heart shape

Researchers at the University of Oxford, working with NHS Digital, in collaboration with experts from the University of Keele, the University of Leeds, Imperial College London, University College London, Barts Health NHS Trust and the Royal Brompton & Harefield NHS Foundation Trust, have published new research that shows that only two thirds of the expected admissions with heart attacks took place at the end of March 2020.

By the end of May, admission rates had partially recovered, but remained below expected levels. In total, by the end of May there had been about 5000 fewer admissions with heart attack in 2020 than would be expected, suggesting that many patients have missed out on lifesaving treatment. The study, published today in The Lancet, used data regularly collected by NHS Digital from NHS Hospital Trusts in England to get up-to-date information about admissions to hospital. Researchers documented a reduction in admissions with heart attack in England at the start of the COVID-19 pandemic by comparing weekly rates in 2020 with those observed in 2019. They are continuing to monitor these trends and will post updated results every month at https://www.ctsu.ox.ac.uk/research/covid-19-acute-coronary-syndromes.

The full story is available on the University of Oxford website

Similar stories

Oxford University academics recognised in Queen’s Birthday Honours

The pioneering work of members of the University, including research into tackling the Coronavirus pandemic, has been recognised in The Queen's Birthday Honours List.

Two Oxford Professors elected as EMBO Members

Professor Robert Klose and Professor Ervin Fodor are two of 64 life scientists to be elected to The European Molecular Biology Organization (EMBO).

Scientists make DNA breakthrough which could identify why some people are more affected by Covid-19

Scientists from the MRC Weatherall Institute of Molecular Medicine at Oxford University have developed a method that allows them to see, with far greater accuracy, how DNA forms large scale structures within a cell nucleus.

AI endoscopy enables 3D surface measurements of pre-cancerous condition in oesophagus

Clinicians and engineers in Oxford have begun using artificial intelligence alongside endoscopy to get more accurate readings of the pre-cancerous condition Barrett’s oesophagus and so determine patients most at risk of developing cancer.

The COVID-19 International Modelling Consortium (CoMo Consortium) enters a new phase

Created in March 2020 to assist policymakers to make use of existing evidence in mathematical and epidemiological models to inform strategies for minimising the impact of COVID-19, the CoMo Consortium brings together mathematical modellers, epidemiologists, health economists and public health experts from more than 40 countries across Africa, Asia and South and North America.

New Head of the Department of Psychiatry – Professor Belinda Lennox

Professor Belinda Lennox has been welcomed to the role of Head of the Department of Psychiatry at the University of Oxford and will take over leadership in October 2021.